Inventor

HWU PATRICK

US12 patents

⚠️ This page may combine multiple inventors who share the name “HWU PATRICK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

US HEALTH

5 patents

US6734014B1May 11, 2004

Methods and compositions for transforming dendritic cells and activating T cells

US HEALTH54 citations95

US7723111B2May 25, 2010

Activated dual specificity lymphocytes and their methods of use

US HEALTH34 citations88

US7378277B2May 27, 2008

Methods and compositions for transforming dendritic cells and activating T cells

US HEALTH3 citations62

US7749967B2Jul 6, 2010

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

US HEALTH2 citations58

US7419957B2Sep 2, 2008

Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods

US HEALTH4 citations58

UNIV TEXAS

2 patents

US11594135B2Feb 28, 2023

Methods of CD40 activation and immune checkpoint blockade

UNIV TEXAS0 citations55

US10894044B2Jan 19, 2021

Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer

UNIV TEXAS1 citations48

ESHHAR ZELIG

1 patent

US8211422B2Jul 3, 2012

Chimeric receptor genes and cells transformed therewith

ESHHAR ZELIG240 citations97

RADVANYI LASZLO

1 patent

US9512401B2Dec 6, 2016

B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

RADVANYI LASZLO12 citations74

MEMGEN INC

1 patent

US12171803B2Dec 24, 2024

Methods of CD40 and toll like receptor immune activation

MEMGEN INC0 citations52

HWU PATRICK

1 patent

US8252545B2Aug 28, 2012

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

HWU PATRICK0 citations41

NANOCRUISE PHARMACEUTICAL LTD

1 patent

US11673966B2Jun 13, 2023

Monoclonal and humanized antibodies to a cancer glycopeptide

NANOCRUISE PHARMACEUTICAL LTD0 citations39